using a modified radioimmunoassay , surface labeling of hla-dr antigens on monocytes revealed reduced densities in patients with active rheumatoid arthritis ( ra ) ( p less than 0.001 ) and in gold-treated patients ( p less than 0.01 ) versus normal controls .
C0003873
rheumatoid
C0018026
gold